3651 results for «384»

Filter By

3651 results

Challenging femoral access and alternative access

03 Mar 2023 – From AfricaPCR 2023

In this session, learn about femoral artery dissection after TAVI, femoral perforation, alternative access for TAVI, and follow discussions about the safest way to perform transfemoral access, among others!

Challenging femoral access and alternative access

Coronary clinical cases - session 2

03 Mar 2023 – From AfricaPCR 2023

This session combines several cases including a case of type V STEMI secondary to calcium embolism during SAVR, another case of failed coronary artery bypass grafting, a third case of coronary artery dissection and a last case where imaging is essential to determine whether it is...

Coronary clinical cases - session 2

Coronary clinical cases - session 1

03 Mar 2023 – From AfricaPCR 2023

This AfricaPCR 2023 session will enable you to study several cases, including that of a 66-year-old male patient with atrial fibrillation, hypothyroidism, previous PCI of RCA, LM to LAD and OM, who was admitted for NSTEMI. Watch the video to find out more!

Coronary clinical cases - session 1

Navigating the complexities of contemporary private practice

03 Mar 2023 – From AfricaPCR 2023

Watch this AfricaPCR 2023 session to learn the basic principles about private practice set up, become familiar with the administrative tools available and regulatory environment governing practice, and understand the importance of institutional, clinical and peer networks in private practice.

Navigating the complexities of contemporary private practice

The importance of IVUS in optimising PCI of the left main coronary artery

03 Mar 2023 – From AfricaPCR 2023

Watch the case of an 89-year-old active male patient with type II diabetes and pulmonary hypertension, awaiting hip replacement, who presented with recently worsening effort dyspnoea, and review his treatment management thanks to the recorded video while following the debate around such intervention.

The importance of IVUS in optimising PCI of the left main coronary artery

Valvular clinical cases

04 Mar 2023 – From AfricaPCR 2023

Watch this session of AfricaPCR 2023 to discover, among others, a case of MViV, an upper limb TAVI combined with PVD intervention, transfemoral TAVI and TMVR in severe native valve disease, or even a bailout TAVI.

Valvular clinical cases

How should I treat a patient with multivessel disease - A patient's journey

04 Mar 2023 – From AfricaPCR 2023

In this session, study the case of a 55-year-old female patient with DM and previous inferior STEMI, who presented with minimal exertion angina, 48% EF and mild MR, and follow her journey to understand how to optimally handle the specifics of patients with multivessel disease.

How should I treat a patient with multivessel disease - A patient's journey

Calcified left main bifurcation PCI: how to evaluate and how best to treat - LIVE case

04 Mar 2023 – From AfricaPCR 2023

A 62-year-old male with hormonal treatment (metastatic prostate carcinoma) presents an exertion angina due to an MVD: severe calcified stenoses of distal left main (medina 1-1-1), mid LAD and prox CX.
Watch how the operators prepare LAD and CX lesions with Rotablator (Burrs: 1.25 + 1.75) then...

Calcified left main bifurcation PCI

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
OPINION Trial: 1-year outcomes

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Didn’t find what you were looking for?